Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature.
baboon syndrome
drug reaction with eosinophilia and systemic symptoms
histopathology
symmetric drug-related intertriginous and flexural exanthema
toxic erythema of chemotherapy
Journal
Journal of cutaneous pathology
ISSN: 1600-0560
Titre abrégé: J Cutan Pathol
Pays: United States
ID NLM: 0425124
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
revised:
08
06
2021
received:
05
04
2021
accepted:
18
06
2021
pubmed:
24
6
2021
medline:
1
3
2022
entrez:
23
6
2021
Statut:
ppublish
Résumé
Symmetric drug-related intertriginous and flexural exanthema (SDRIFE) is a cutaneous drug reaction characterized by gluteal/anogenital erythema and symmetric involvement of other intertriginous location(s) without systemic signs. Clinicopathologic characterization has been limited to case reports and small series. We describe 19 new cases and review the literature to better define the clinical and histopathologic spectrum of SDRIFE. Pathology archives were searched for "SDRIFE" and "baboon syndrome." Cases meeting clinical criteria were included. Clinical and histopathologic features were recorded. Previous reports of SDRIFE with histopathologic descriptions were reviewed. Nineteen new cases were included, over half triggered by antibiotics. Six new causative medications were identified. Median onset was 7 days. Typical lesions were erythematous plaques or papules with or without scale. The most common histopathologic finding was superficial perivascular lymphocytic infiltrate followed by dermal eosinophils, spongiosis, and orthokeratosis. Basal vacuolization and apoptotic keratinocytes were less common. Interstitial histiocytes were present in almost half of our cases. Other findings included atypical lymphocytes and "flame figure." Appreciation of the range of inciting medications and clinicopathologic features in SDRIFE will improve recognition of this condition. Although many histopathologic features overlap with other common dermatitides, biopsy may assist in excluding key clinical mimics.
Sections du résumé
BACKGROUND
BACKGROUND
Symmetric drug-related intertriginous and flexural exanthema (SDRIFE) is a cutaneous drug reaction characterized by gluteal/anogenital erythema and symmetric involvement of other intertriginous location(s) without systemic signs. Clinicopathologic characterization has been limited to case reports and small series. We describe 19 new cases and review the literature to better define the clinical and histopathologic spectrum of SDRIFE.
METHODS
METHODS
Pathology archives were searched for "SDRIFE" and "baboon syndrome." Cases meeting clinical criteria were included. Clinical and histopathologic features were recorded. Previous reports of SDRIFE with histopathologic descriptions were reviewed.
RESULTS
RESULTS
Nineteen new cases were included, over half triggered by antibiotics. Six new causative medications were identified. Median onset was 7 days. Typical lesions were erythematous plaques or papules with or without scale. The most common histopathologic finding was superficial perivascular lymphocytic infiltrate followed by dermal eosinophils, spongiosis, and orthokeratosis. Basal vacuolization and apoptotic keratinocytes were less common. Interstitial histiocytes were present in almost half of our cases. Other findings included atypical lymphocytes and "flame figure."
CONCLUSIONS
CONCLUSIONS
Appreciation of the range of inciting medications and clinicopathologic features in SDRIFE will improve recognition of this condition. Although many histopathologic features overlap with other common dermatitides, biopsy may assist in excluding key clinical mimics.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1471-1479Informations de copyright
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Häusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis. 2004;51(5-6):297-310.
Nespoulous L, Matei I, Charissoux A, Bédane C, Assikar S. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature. Contact Dermatitis. 2018;79(6):378-380.
Wolf R, Tüzün Y. Baboon syndrome and toxic erythema of chemotherapy: fold (intertriginous) dermatoses. Clin Dermatol. 2015;33(4):462-465.
Blackmur JP, Lammy S, Baring DEC. Baboon syndrome: an unusual complication arising from antibiotic treatment of tonsillitis and review of the literature. BMJ Case Rep. 2013;2013:bcr2013201977.
Bulur I, Keseroglu HO, Saracoglu ZN, Gönül M. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) associated with infliximab. J Dermatol Case Rep. 2015;9(1):12-14.
Muresan A-M, Metze D, Böer-Auer A, Braun SA. Histopathological spectrum and immunophenotypic characterization of symmetrical drug-related intertriginous and flexural exanthema. Am J Dermatopathol. 2021;43(2):103-111.
Daito J, Hanada K, Katoh N, et al. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir. Dermatology. 2009;218(1):60-62.
Huynh T, Hughey LC, McKay K, Carney C, Sami N. Systemic drug-related intertriginous and flexural exanthema from radio contrast media: a series of 3 cases. JAAD Case Rep. 2015;1(3):147-149.
Herfs H, Schirren CG, Przybilla B, Plewig G. “Baboon syndrome”. A particular manifestation of hematogenous contact reaction. Hautarzt. 1993;44(7):466-469.
Duve S, Worret W, Hofmann H. The baboon syndrome: a manifestation of haematogenous contact-type dermatitis. Acta Derm Venereol. 1994;74(6):480-481.
Wakelin SH, Sidhu S, Orton DI, Chia Y, Shaw S. Amoxycillin-induced flexural exanthem. Clin Exp Dermatol. 1999;24(2):71-73.
Wolf R, Elman M, Brenner S. Drug-induced “intertrigo”. Int J Dermatol. 1993;32(7):515-516.
Goossens C, Sass U, Song M. Baboon syndrome. Dermatology. 1997;194(4):421-422.
Panhans-Gross A, Gall H, Peter RU. Baboon syndrome after oral penicillin. Contact Dermatitis. 1999;41(6):352-353.
Barbaud A, Tréchot P, Granel F, et al. A baboon syndrome induced by intravenous human immunoglobulins: report of a case and immunological analysis. Dermatology. 1999;199(3):258-260.
Lechner T, Grytzmann B, Bäurle G. Hematogenous allergic contact dermatitis after oral administration of nystatin. Mykosen. 1987;30(3):143-146.
Sanz Sánchez T, Sánchez-Pérez J, Aragüés M, García-Díez A. Flare-up reaction of pseudoephedrine baboon syndrome after positive patch test. Contact Dermatitis. 2000;42(5):312-313.
Gordon E. Baboon syndrome caused by Salasate. J Drugs Dermatol. 2002;1(1):66.
Montag G, Weber L, Gall H. Baboon-syndrom auf Allopurinol. Aktuelle Derm. 1996;22(11):311-313.
Helmbold P, Hegemann B, Dickert C, Marsch WC. Symmetric ptychotropic and nonpigmenting fixed drug eruption due to cimetidine (so-called baboon syndrome). Dermatology. 1998;197(4):402-403.
Garcia-Bravo B, Bosco Repiso J, Camacho F. Systemic contact dermatitis due to deflazacort. Contact Dermatitis. 2000;43(6):359-360.
Chowdhury MM, Patel GK, Inaloz HS, Holt PJ. Hydroxyurea-induced skin disease mimicking the baboon syndrome. Clin Exp Dermatol. 1999;24(4):336-337.
Elmariah SB, Cheung W, Wang N, Kamino H, Pomeranz MK. Systemic drug-related intertriginous and flexural exanthema (SDRIFE). Dermatol Online J. 2009;15(8):3.
Sans V, Jouary T, Hubiche T, Smith D, Milpied B, Taieb A. Baboon syndrome induced by cetuximab. Arch Dermatol. 2008;144(2):272-274.
Watanabe T, Yamada N, Yoshida Y, Yamamoto O. A case of symmetrical drug-related intertriginous and flexural exanthema induced by loflazepate ethyl. J Eur Acad Dermatol Venereol. 2010;3(24):357-358.
Ferreira O, Mota A, Morais P, Cunha AP, Azevedo F. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by telmisartan-hydrochlorothiazide. Cutan Ocul Toxicol. 2010;29(4):293-295.
Aktürk AŞ, Bayramgürler D, Salman S, Yıldız KD, Demirsoy EO. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by oral metronidazole. Cutan Ocul Toxicol. 2014;33(4):337-338.
Cohen PR. Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid. Dermatol Online J. 2015;21(8):13030/qt5kk0g864.
Kurtzman DJB, Oulton J, Erickson C, Curiel-Lewandrowski C. Everolimus-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE). Dermatitis. 2016;27(2):76-77.
Karadag AS, Ozlu E, Akdeniz N, et al. Oral mucosal involvement and petechial lesions: a SDRIFE case with unusual findings. Cutan Ocul Toxicol. 2016;35(2):157-159.
André MC, Silva R, Filipe PL, Lopes A, de Almeida LMS. Systemic contact allergy to penicillin after prick and intradermal tests. Ann Allergy Asthma Immunol. 2011;106(2):174-175.
Binitha MP, Sasidharanpillai S, John R, Sherjeena PVB. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine. Indian J Pharmacol. 2014;46(5):551-552.
Shivani N, Kerr H. A case of SDRIFE induced by fluconazole. J Am Acad Dermatol. 2016;74(5):AB89.
May UC. Baboon syndrome (SDRIFE): a rare cutaneous reaction in a Filipino woman induced by intravenous immunoglobulin G (IVIg). J Am Acad Dermatol. 2016;74:AB45.
Obara K, Maejima H, Katayama C, Takasu H, Amoh Y. A case of symmetrical drug-related intertriginous and flexural exanthema induced by acetaminophen. J Dermatol. 2014;41(12):1132-1133.
Powers R, Gordon R, Roberts K, Kovach R. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil. Cutis. 2012;89(5):225-228.
Malissen N, Bourrain J-L, Chiriac A, et al. Symmetrical intertriginous and flexural exanthema due to bortezumib (a proteasome inhibitor) given for myeloma. Acta Derm Venereol. 2016;96(7):995-996.
Rao A, Francis N, Morar N. Clozapine-induced symmetrical drug-related intertriginous and flexural exanthema: first reported cases. Br J Dermatol. 2012;166(5):1142-1143.
Lora V, Capitanio B, Cota C. A symmetrical flexural rash. Pediatr Dermatol. 2016;33(3):345-346.
Lee HY, Philippidou M, Schey S, et al. Flexural eruption in two hospitalized patients. Clin Exp Dermatol. 2013;38(8):943-945.
Kardaun SH, Tupker RA. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) induced by omeprazole: correspondence. Int J Dermatol. 2012;51(9):1134-1137.
Can C, Yazicioglu M, Ozdemir PG, Kilavuz S, Tastekin E. Symmetrical drug-related intertriginous and flexural exanthema induced by two different antibiotics. Allergol Immunopathol (Madr). 2014;42(2):173-175.
Janjua SA, Pastar Z, Iftikhar N, Ammad S. Intertriginous eruption induced by terbinafine: a review of baboon syndrome. Int J Dermatol. 2017;56(1):100-103.
Erfan G, Yanik ME, Kaya S, Tasolar K, Oznur M, Kulac M. Symmetrical drug-related intertriginous and flexural exanthema due to codeine. Indian J Dermatol Venereol Leprol. 2015;81(4):405-406.
Hassanandani T, Panda M, Agarwal A, Das A. Rising trends of symmetrical drug related intertriginous and flexural exanthem due to Itraconazole in patients with superficial dermatophytosis: a case series of 12 patients from eastern part of India. Dermatol Ther. 2020;33(6):e13911.
Handisurya A, Stingl G, Wöhrl S. SDRIFE (baboon syndrome) induced by penicillin. Clin Exp Dermatol. 2009;34(3):355-357.
Wolf R, Brenner S, Krakowski A. Intertriginous drug eruption. Acta Derm Venereol. 1992;72(6):441-442.
Wolf R, Orion E, Matz H. The baboon syndrome or intertriginous drug eruption: a report of eleven cases and a second look at its pathomechanism. Dermatol Online J. 2003;9(3):2.
Akkari H, Belhadjali H, Youssef M, Mokni S, Zili J. Baboon syndrome induced by hydroxyzine. Indian J Dermatol. 2013;58(3):244.
Scherrer M, Araujo MG, Farah K. Tacrolimus-induced symmetric drug-related intertriginous and flexural exanthema (SDRIFE). Contact Derm. 2018;78(6):414-416.
Sahu K, Sirka CS, Pradhan S, Rout AN. Co-occurrence of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) and pigmented fixed drug eruption (FDE) in a single patient due to doxycycline: a case report. Indian Dermatol Online J. 2020;11(1):62-64.
Copps B, Lacroix J-P, Sasseville D. Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib. JAAD Case Rep. 2020;6(3):172-175.
Karagöl C, Ceran A, Güngör A, Akman AÖ, Misirlioğlu ED. Baboon syndrome associated with ampicillin sulbactam. J Allergy Clin Immunol Pract. 2018;6(6):2106-2107.
Yang S-Y, Lan C-C, Hu SC-S. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by golimumab. Int J Dermatol. 2017;56(5):571-572.
Megna M, Cinelli E, Napolitano M, Fabbrocini G, Patruno C. Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy. Contact Dermatitis. 2019;81(6):451-454.
Labadie JG, Florek AG, Croitoru A, Liu W, Krunic AL. First case of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) due to Berberine, an over-the-counter herbal glycemic control agent. Int J Dermatol. 2018;57(9):e68-e70.
Magnolo N, Metze D, Ständer S. Pustulobullous variant of SDRIFE (symmetrical drug-related intertriginous and flexural exanthema). J Dtsch Dermatol Ges. 2017;15(6):657-659.
Rodríguez-Garijo N, Bielsa I, Mascaró JM Jr, et al. Reactive granulomatous dermatitis as a histological pattern including manifestations of interstitial granulomatous dermatitis and palisaded neutrophilic and granulomatous dermatitis: a study of 52 patients. J Eur Acad Dermatol Venereol. 2021;35(4):988-994.
Rosenbach M, English JC 3rd. Reactive granulomatous dermatitis: a review of palisaded neutrophilic and granulomatous dermatitis, interstitial granulomatous dermatitis, interstitial granulomatous drug reaction, and a proposed reclassification. Dermatol Clin. 2015;33(3):373-387.
Coutinho I, Pereira N, Gouveia M, Cardoso JC, Tellechea O. Interstitial granulomatous dermatitis: a clinicopathological study. Am J Dermatopathol. 2015;37(8):614-619.
Morais KL, Miyamoto D, Maruta CW, Aoki V. Diagnostic approach of eosinophilic spongiosis. An Bras Dermatol. 2019;94(6):724-728.
Wolf R, Barzilai A, Davidovici B. Intertriginous lymphomatoid drug eruption. Int J Dermatol. 2010;49(10):1207-1209.
Pulitzer MP, Nolan KA, Oshman RG, Phelps RG. CD30 lymphomatoid drug reactions. Am J Dermatopathol. 2013;35(3):343-350.
Magro CM, Olson LC, Nguyen GH, de Feraudy SM. CD30 positive lymphomatoid angiocentric drug reactions: characterization of a series of 20 cases. Am J Dermatopathol. 2017;39(7):508-517.
Llamas-Velasco M, Godoy A, Sánchez-Pérez J, García-Diez A, Fraga J. Acute generalized exanthematous pustulosis with histopathologic findings of lymphomatoid drug reaction. Am J Dermatopathol. 2013;35(6):690-691.
Skowron F, Bensaid B, Balme B, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases. J Eur Acad Dermatol Venereol. 2015;29(11):2199-2205.
Winnicki M, Shear NH. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE). Am J Clin Dermatol. 2011;12(3):171-180.
Smith SM, Milam PB, Fabbro SK, Gru AA, Kaffenberger BH. Malignant intertrigo: a subset of toxic erythema of chemotherapy requiring recognition. JAAD Case Rep. 2016;2(6):476-481.
Bolognia JL, Cooper DL, Glusac EJ. Toxic erythema of chemotherapy: a useful clinical term. J Am Acad Dermatol. 2008;59(3):524-529.
Hunjan MK, Nowsheen S, Ramos-Rodriguez AJ, et al. Clinical and histopathological spectrum of toxic erythema of chemotherapy in patients who have undergone allogeneic hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther. 2019;12(1):19-25.
Halevy S, Kardaun SH, Davidovici B, Wechsler J. EuroSCAR and RegiSCAR study group. The spectrum of histopathological features in acute generalized exanthematous pustulosis: a study of 102 cases. Br J Dermatol. 2010;163(6):1245-1252.